Drug Profile
SV BR1 GM breast cancer vaccine companion diagnostic - Briacell Therapeutics
Alternative Names: BriaDx™; BriaVax™ companion diagnostic - briacell; BriaVax™ DX -BriacellLatest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator BriaCell Therapeutics Corp
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast cancer
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for preclinical development in Breast-cancer(Diagnosis) in USA
- 29 Nov 2016 BriaCell Therapeutics files for patent protection with the US Patent and Trademark Office for SV BR1 GM breast cancer vaccine companion diagnostic in USA
- 14 Sep 2015 Preclinical trials in Breast cancer (Diagnosis) in USA (unspecified route)